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Inducible resistance to glycopeptides (VanA type) is mediated by 
plasmids and the genes are carried by Tnl546-like transposons. Seven 
polypeptides are encoded by Tn1546 that can be assigned to four 
functional groups: regulation of resistance gene expression (VanR and 
Vans), synthesis of depsipeptide D-Ala-11-Lac (VanH and VanA), 
hydrolysis of D-Ala-D-Ala-containing peptidoglycan precursors 
(VanX and VanY) and teicoplanin resistance (VanZ). The VanH 
dehydrogenaw and the VaiiA ligase synthesize D-Ala-D-Lac, which 
replaces 1)-Ala-D-Ala in the peptidoglycan synthesis pathway. This 
modification reduces glycopeptide affinity. Strains with the VanU 
phenotype are inducibly resistant to vaiiconiycin also by production 
of D-Ala-D-Lac. In certain isolates, the genes conferring the VanU 
phenotype are found on chromosomal elements that can transfer 
among enterococci and in others they are borne by self-transferable 
plamids. Etzterococcui j i e c i i m  clinical isolates of type D are consti- 
tutively resistant to vancoinycin and to low levels of teicoplanin, also 
by production of D-Ala-11-Lac. The compactness of the van gene 
clusters as well as the dual inechanisni of resistance indicate that 
glycopeptide resistance is ancient. Analysis of the genes and gene 
order in the oanA and uaiiR operons and study of the base coni- 
position within the clusters suggest that genes from different origins 
have been recruited. Comparison of structural genes for D-Ala:I)- 
Lac ligases is compatible with the notion of an origin, in the glyco- 
peptide-producing strains, of acquired resistance in enterococci. 
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There is a vast consensus on the fact that Streptococcus pyogcws, S. 
ptirutnoniae, Haeiiiophilus influoizac and Moraxella catarrhalis represent 
the prevailing bacterial pathogens of community-acquired upper and 
lower respiratory tract infections. Their specific incidence as causative 
agents of the more coiiinion syndromes is known to vary, sometimes 
profoundly, depending on geographic location, and the same holds 
true for the rates of resistance to antiniicrobial drugs. S. py~~qcncs  has 
remained totally susceptible to p-lactanis but has accumulated, in 
countries such as Finland and Italy, a large amount of resistance to 
the available inacrolides; this resistance has originated, however, by 
distinct molecular mechanisms, possibly implicating different degrees 
of clinical relevance. Europe does not escape the threat posed by the 
present pandemic of penicillin resistance in S. pncunioiriae although, 
as expected, there are countries like Spain, France and the Slovak 
Republic that are highly affected and others, including Germany, 
Italy, The Netherlands and the Scandinavian region, that are 
comparatively \pared. In several sites, multiple resistance has been 
described in S. ptieuumniue, and the iiio\t affected drugs include 
penicillin, the niacrolides, cotrimoxazole and tetracycline. In H .  
i?fiiienrar, synthesis of /%lactanlases is the main trait of resistance 
expressed. Lack of susceptibility to /%lactams dictated by different 
mechanisms reniains extremely rare. Large variations in the incidence 
of this character are apparent when considering the various European 
countries. France and Spain are again widely a f k t e d ,  while 
Germany, The Netherlands and Italy display rates of p-Iactaniase- 
positive H ii!fluerzzae of less than 10%. M. ~ a f a r r h a l i s  nimt be 
considered generally resistant to non-protected .iminopeiiicilli~i~, 
since over 90% of these organisms produceP-lactamases. Thc po\sible 
reasons for the vast variations in the incidence of resistance observcd 
in Europe will be analyzed. Finally, the fact that at least in thc 
respiratory tract and in the imiiiunocoiiipetmt host, exprc\\ion of 
resistance does not always predict lack of clinical efficacy when the 
drug found to be inactive in vitro is employed hi- a couisc of therapy 
in noii-hospitalized patients will be discussed. 
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Staphylococci that demonstrate reduced susceptibility to vaiiconiyciri 
or other glycopeptides have been isolated in Japan, the USA and 
Europe. Of  the three isolates of Staphylocornrs aweus with variconiycin 
MlCs of 8 iiig/L reported in the USA, two resulted in vancomycin 
treatment failures. Laboratory detection of VRSA can be difficult. 
Broth microdilution tests work well, but disk diffusion does not 
differentiate vancoiiiycin-resistant from ~aiicomycin~su,ceptiblc iso- 
lates. In response to the emergence of the resistant stram, the CIX: 
published guidelines for the control of VRSA in healthcare settings. 
The  guidelines stress healthcare worker education, mon~toring o f  
infection control policies, and the need to accurate laboratory 
procedures. To date, no spread of VRSA ha.: been docuiiicntcd in  
healthcare setting, but such strains are common i n  J a p n .  The 
emergence of vanconiycin resistance in staphylococci w i l l  coiitiiiue 
to pose challenges to both the clinical laboratory and phy\icians. 
W] Selective pressure by antibiotic use in livestock 
W. Witte, 1. Klare, G. Werner. RoOerr Koch Ziistiturc., W r i i ( p i d c ,  
Gcumaiiy 
The  use ofthe glycopeptide avoparcin as a feed additive has obviously 
created a considerable reservoir of transferable glycopeptide resistance 
(variA gene cluster) in Errreroroccus faeriirrii in animal husbandry. 
Glycopeptide-resistant E. $ecium (CKEF) can easily reach human\ 
via meat products (poultry, minced pork) and thus be fiiund in fecal 
samples from non-hospitalized humans in the coininuiiiry G K E F  o f  
different ecological origin (clinical cases, meat products, anini~ls) are 
polyclonal, as deduced from molecular typing. Also, conjugative 
plasmids carrying the uawA gene cluster are obviously diffcrcnt. I'CR 
characterization revealed that the vanA gene cluster itself w.is 
homogeneous in the majority of GREF froin human md'dninial 
sources. Our  results indicate a wide dissemination of iuari,4 among 
different E. $miurn strains (and also among difrerrnt plasniids) :ind i n  
different resei-voirs created by selective pressure of glyc(ipeptide use. 
